About VESTECK
VESTECK is a Healthcare company based in West Chester (United States) founded in 2019. Developer of a device for the treatment of aortic aneurysms. VESTECK has raised $12.86 million across 5 funding rounds from investors including New World Angels, DeepWork Capital and Ocean Azul Partners. Its chief executive, as recorded, is Joseph W Rafferty. VESTECK offers products and services including Suture-Tight™. Its focus areas include Life Sciences, Surgical Instruments, Surgical Access and Closure and Surgical Sutures. Its legal entity is Vesteck Inc. Its competitors include Mercator MedSystems, Nectero Medical and PharmaIN; 3 of its 3 listed competitors have raised funding.
Company details
Vesteck was founded in 2019 and is based in West Chester, United States. Focus is placed on medical devices within the cardiovascular sector. A nitinol suture delivery catheter called Suture-Tight is offered, by which endovascular aortic repair grafts are secured to the aorta. Graft migration and leaks are thereby addressed in patients with aortic aneurysms. Operations center on device development for aneurysm management.
- Headquarters West Chester, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website vesteck.com
- Social LinkedIn YouTube
- Legal Name Vesteck Inc
- Total Equity Funding$12.86M (USD)
in 5 rounds
- Latest Funding Round$353.58K (USD), Series A
Oct 2025
- InvestorsNew World Angels
& 7 more
Products & Services of VESTECK
VESTECK offers a comprehensive portfolio of products and services, including Suture-Tight™.
Advanced device for fixing endografts in EVAR and TEVAR procedures.
Apps and channels of VESTECK
its YouTube channel Vesteck Inc has 1 subscribers.
Funding Insights of VESTECK
VESTECK has successfully raised a total of $12.86M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $353.58 thousand completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $12.86M
- Total Rounds 5
- Last Round Series A — $353,578
- First Round $4.3M
(Aug 2021)
- Investors Count 8
All 5 funding rounds of VESTECK with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2025 | $353,578 | Series A | – | – | – |
| Dec 2022 | $2.26M | Series A | – | – | – |
| Jan 2022 | $5.95M | Series A | – | New World Angels | |
| Sep 2021 | Series A | – | BioAdvance, Angel Star Ventures | – | |
| Aug 2021 | $4.3M | Series A | – | New World Angels |
8 investors in total: 8 institutional.
Investors in VESTECK
VESTECK has secured backing from 8 investors, including venture fund investors. Prominent investors backing the company include New World Angels, DeepWork Capital and Ocean Azul Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage funding and guidance are provided to Florida entrepreneurs. | 2003 | newworldangels.com | Boca Raton, United States | |
Venture capital firm investing in multiple sectors | deepworkcapital.com | Orlando, United States | ||
| oceanazulpartners.com | ||||
| bioadvance.com | ||||
Early-stage startups are supported with funding and mentorship by Angel Star Ventures. | angelstarventures.com | Chadds Ford, USA | ||
Technology ecosystem growth is supported in Southeastern Pennsylvania. | sep.benfranklin.org | Philadelphia, United States | ||
| delawarecrossing.org | ||||
Early-stage investments are made in high-growth startups by this group. | 1999 | robinhoodventures.com | Philadelphia, United States |
Investor details for VESTECK
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of VESTECK
1 people are tracked at VESTECK (1 in leadership).
| Name | Role | Group |
|---|---|---|
Joseph W Rafferty | CEO | Leadership |
Complete people profiles for VESTECK
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of VESTECK
3 dated milestones of VESTECK across 6 years, from founding to its latest funding, stage changes and deals.
- Founded VESTECK is founded.
- Funding First funding round of $4.3M.
- Funding Latest funding round, Series A, of $354K.
Competitors of VESTECK
VESTECK has 3 listed competitors in our database, 3 of them funded. They include Mercator MedSystems, Nectero Medical and PharmaIN.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| mercatormed.com | 2000 | San Leandro, United States | $31.8M | Catheter-guided microfluid injection systems are developed for targeted tissue therapies. | ||
| necteromedical.com | 2019 | Bethlehem, United States | $115.5M | 6 | An endovascular device for treating abdominal aortic aneurysms is developed. | |
| pharmain.com | 2001 | Bothell, United States | $1.5M | Proprietary drug delivery platforms are developed for API enhancement. |
Detailed competitors of VESTECK
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Medical Equipment & Supplies
3 companies that operate in the same segment as VESTECK (Medical Equipment & Supplies) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Robotic waterjet system for prostate tissue removal is developed. | 2009 | Redwood City, California, United States | USD 348.84 M | USD 308.05 M | 756 | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.62 M | 91 | ||
Injectable packaging, containment, and delivery solutions are manufactured. | 1923 | Exton, Pennsylvania, United States | USD 3.07 B | 10,600 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Vesteck
Complete news archive for VESTECK
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about VESTECK
VESTECK was founded in 2019 and raised its 1st funding round 2 years after it was founded.
VESTECK is headquartered in West Chester, United States. It is registered at West Chester, Pennsylvania, United States.
Joseph W Rafferty is the CEO of VESTECK, as recorded in our data.
VESTECK is a funded company, having raised a total of $12.86M across 5 funding rounds to date. The company's 1st funding round was a Series A of $4.3M, raised on Aug 2021.
Vesteck was founded in 2019 and is based in West Chester, United States. Focus is placed on medical devices within the cardiovascular sector. A nitinol suture delivery catheter called Suture-Tight is offered, by which endovascular aortic repair grafts are secured to the aorta. Graft migration and leaks are thereby addressed in patients with aortic aneurysms. Operations center on device development for aneurysm management.
VESTECK's top competitors include Mercator MedSystems, PharmaIN and Nectero Medical.
VESTECK offers Suture-Tight™.
VESTECK has 8 investors. Key investors include New World Angels, DeepWork Capital, Ocean Azul Partners, BioAdvance, and Angel Star Ventures.
VESTECK operates through Vesteck Inc.